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Enormous progress has been made in identifying chromatin ‘‘signatures’’ that define tissue-specific
transcriptional networks. Three recent studies by Rada-Iglesias et al. (2012), Wamstad et al. (2012), and
Paige et al. (2012) track such signatures during cellular differentiation, revealing a richer understanding of
gene regulation and providing hints of new phenomena.In multicellular organisms, distinct cell
types are specified by differential gene
expression. This occurs through binding
of DNA regulatory elements—composed
primarily of gene promoters and distal
enhancer sequences—by transcription
factors that modify chromatin structure
to selectively activate or repress genes
in the appropriate patterns for each
cell type. Specific histone modification
patterns characterize active versus inac-
tive promoters, and can be used to
pinpoint the locations of distal enhancers
that regulate a given promoter. The
ENCODE Project Consortium has exten-
sively employed chromatin immunopre-
cipitation coupled with high-throughput
DNA sequencing (ChIP-seq) to map the
genome-wide occurrence of histone
modifications, transcription factor bind-
ing, and other structural features asso-
ciated with gene regulation—which
collectively might be termed the ‘‘epige-
nome’’—in a large number of tissue and
cell types, and this has served to define
characteristic epigenomic patterns for
multiple cell types (Stamatoyannopoulos,
2012).
Specific cell types, however, arise from
organized programs of differentiation that
originate in pluripotent stem cells and
progress through multipotent progeni-
tors. With respect to DNA regulatory
elements, how transcription factor bind-
ing patterns and modifications to chro-
matin structure change during sequential
cell fate decisions is not well understood.
Three recent publications in Cell and Cell
Stem Cell address this question using
in vitro differentiation of embryonic stem
cells (ESCs). Wamstad et al. examine
four stages of murine cardiac differen-
tiation for gene expression and histonemodifications associated with both active
and inactive gene promoters and en-
hancers. Paige et al. investigate histone
modifications associated with gene
promoters during cardiac differentiation
from human ESCs. Finally, Rada-Iglesias
et al. (in this issue of Cell Stem Cell) follow
the formation of neural crest cells (NCCs)
from human ESCs via ChIP-seq for
histone modifications associated with
distal enhancers.
Despite the significant differences
between these studies—e.g., the differ-
entiation programs examined, and the
concentration on promoters versus
enhancers—the general principles that
emerge from them are strikingly similar.
Perhaps the major conclusion, as from
the ENCODE project in general, is that
the combination of epigenomic informa-
tion with gene expression data is drasti-
cally more informative than expression
data alone. For example, Wamstad et al.
show that genes that have similar ex-
pression profiles through cardiac differ-
entiation can exhibit a number of different
patterns of chromatin modifications at
their promoters. These patterns, in turn,
often correlate with broadly defined func-
tional distinctions between the genes
themselves: for example, between genes
whose products are involved in meta-
bolism versus genes whose products
are involved in cell signaling. In Paige
et al., use of gene expression analyses
alone served to identify cardiac-specific
proteins in differentiating human ESCs,
but the combination of gene expression
with chromatin modification data sets
allowed them to classify cardiac-specific
genes into categories based on func-
tion and was able to predict tran-
scription factors that serve as cardiacCell Stem Cell 11,regulators. Thus, while expression anal-
yses by themselves readily identify
lineage-specific genes, genes can be
further classified according to function
using commonalities in the spatial and
temporal histone modification patterns
associated with them.
Importantly, the combined analyses
of gene expression and histone modifi-
cation patterns through multiple stages
of differentiation enabled the authors in
each study to predict novel roles for
transcription factors in the differentiation
programs they examined. Most strikingly,
Rada-Iglesias et al. (2012) perform anal-
yses of recurring DNA sequence motifs
in their population of NCC-specific active
enhancers, and from these predict that in
addition to TFAP2A—a factor previously
implicated in neural crest specification—
the orphan nuclear receptors NR2F1/2
also play a role in proper differentia-
tion of NCCs. They then find support
for such a role via NR2F1 knockdown
in differentiating ESCs and by morpho-
lino-based knockdown experiments in
Xenopus. Similarly, analyses performed
by both Paige et al. and Wamstad et al.
implicate MEIS transcription factors in
their respective cardiac differentiation
programs. While prior studies have impli-
cated Meis1 in cardiac development,
Paige et al. demonstrate a previously un-
characterized role for the related factor
MEIS2 in human cardiac differentiation
simply by noting that the pattern of his-
tone modifications at the MEIS2 pro-
moter over the course of differentiation
resembles that of other cardiac regula-
tors. These studies therefore underscore
the notion that epigenomic informa-
tion leads to more refined models of
gene regulatory networks with greaterNovember 2, 2012 ª2012 Elsevier Inc. 581
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Previewspredictive value than those assembled
using gene expression alone.
Intriguing hints of new biology also
emerge from these studies. For example,
by examining promoter-proximal histone
modifications, Paige et al. are able to
distinguish between broadly defined
‘‘structural’’ and ‘‘regulatory’’ gene cate-
gories among known neuroectodermal
and mesodermal markers, even though
none of these genes are expressed at
significant levels in their human cardiac
differentiation model. This remarkable
observation implies that careful analysis
of dynamic epigenomic patterns followed
through the specification of one lineage
can allow one to extract regulatory
information about other, entirely distinct
lineages, even in the absence of gene
expression. This phenomenon could be
used to analyze lineages that are not
otherwise amenable to genome-wide
techniques due to limited cell numbers
and/or a transient nature.
These studies also raise interesting
questions regarding genome-wide sur-
veys of distal enhancer populations. For
example, the majority of the ‘‘enhancers’’
Wamstad et al. define are actually never
‘‘active’’ (i.e., associated with expressed
genes) at any stage that they analyze.
Previous studies from theWysocka group
and others have suggested that while
monomethylation of histone H3 lysine 4
(H3K4Me1) is a general marker for distal
enhancers, genuinely ‘‘active’’ enhancers582 Cell Stem Cell 11, November 2, 2012 ª2possess additional marks, such as asso-
ciation with the transcription cofactor
p300 and/or histone hyperacetylation
(Creyghton et al., 2010; Rada-Iglesias
et al., 2011). Enhancers that lack these
latter marks have been termed ‘‘poised.’’
Wamstad et al., however, observe that
only a very small number of the cardiac
enhancers that exhibit the poised modi-
fication pattern at an early stage of
differentiation ever become active at
a later stage. Instead, later stages draw
the majority of both their poised and
active enhancers from groups of se-
quences that are distinct from the
enhancer populations of their precursors.
Thus, it is unclear what these H3K4Me1-
marked regions actually represent, and
therefore the term poised may be mis-
leading. In a similar vein, Rada-Iglesias
et al. find that the majority of promoter-
distal sequences bound by TFAP2A are
not associated with the NCC-specific
enhancers that they define by histone
modifications. The significance of these
additional binding sites is unknown—do
they represent nonspecific TFAP2A-
binding ‘‘noise’’ in these cells, or do they
hint at an entirely distinct mode of regu-
lation involving this transcription factor,
one perhaps not directly associated
with gene activation? Wamstad et al.
reasonably speculate that their poised
enhancers represent sequences that are
active only in other lineages, but it is
possible that they, too, represent hints of012 Elsevier Inc.a novel mode of regulation, such as
nuclear architecture.
These studies indicate that despite the
vast volume of data that the ENCODE
project and related efforts have pro-
duced, the era of epigenomics is still
in its infancy. Moreover, the ability to
monitor epigenomes throughout the
progression of cellular differentiation in
model systems promises not only to
more precisely delineate networks of
gene regulation and protein function,
but also potentially to reveal new and
unanticipated phenomena.REFERENCES
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